The Role of the Infusion Nurse in Monoclonal Antibody Administration

Recorded On: 12/14/2022

Monoclonal antibodies (mAbs) are used as an innovative and life-changing treatment and in prevention of an array of diagnoses and disorders. During this session, we will discuss the history of mAb development, how they differ from normal human antibody production, and the unique features of these medications versus more traditional drug therapies. In this presentation, we will also explore the inherent risks in these agents, the etiology of infusion reactions (IR), nursing strategies to mitigate risks, the assessment and nursing interventions for an IR, and considerations for home administration.  

Learning Objectives: At the conclusion of this session, participants will be able to: 
• Discuss the development of monoclonal antibodies (mAb) and the manufacturing processes designed to decrease adverse events
• Recognize 2 signs that may indicate a patient has developed antidrug antibodies
• Identify nursing strategies to mitigate the risk of an infusion reaction
• List the immediate steps in the management an acute infusion reaction

Barbara McElroy, MSN, CRNI®, VA-BC

Barbara McElroy is a clinical educator with 3 decades of experience in infusion and oncology nursing in a variety of settings including the home, clinic, and hospital.  She is an active contributor, writer, and speaker for multiple professional organizations with expertise in standards of care, evidence-based practice, and quality improvement initiatives.  Barbara is experienced as a nursing faculty in both pre- and post-license BSN programs; director of an LPN IV certificate program; and provides expertise in the standard of care in legal cases. She holds an MSN in nursing education and certifications in vascular access and infusion nursing. Barbara divides her time between the New Hampshire White Mountains and the Texas Hill Country and can be reached at

CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

Contact Hours: This session has been approved for 1 contact hour

Expiration date for receipt of contact hours: December 14, 2025

To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.


The Role of the Infusion Nurse in Monoclonal Antibody Administration
Live event: 12/14/2022 at 1:00 PM (EST) You must register to access.
Webinar Evaluation
Printable Certificate You must register to access.